Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC), 2326 October 2023: GLP-1 receptor agonists available evidence not supporting link with thyroid cancer
10.3389/fendo.2023.1148556 99 YaoY.TangY.QinH.MengR.ZhangC.ZhangY.et al (2023)
How do people with refractory irritable bowel syndrome perceive hypnotherapy?: Qualitative study
For example, a small-molecule inhibitor of p53, pifithrin-, was isolated by Komarov et al
Accessed June 16, 2020
When adverse effects occurred, they were typically mild and transient, with the most common being mild to moderate headaches (similar frequency to placebo groups), minor injection site reactions (redness, slight swelling), and gastrointestinal effects at higher oral doses (nausea, diarrhea)